世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040423

トゥレット症候群治療薬の世界市場(2024-2028)

TechNavio

Global Tourettes Syndrome Drugs Market 2024-2028

発刊日 2024/07/09

言語英語

体裁PDF/157ページ

ライセンス/価格157ページ

0000040423

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

トゥレット症候群治療薬市場は、2023年から2028年の間に6億4,210万米ドル、予測期間中のCAGRは6.78%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、トゥレット症候群に対する認識の高まり、世界中でトゥレット症候群の症例が増加していること、費用対効果の高い治療に対する需要が高まっていることなどが牽引しています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 抗精神病薬
      ◇ 非抗精神病薬
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、トゥレット症候群に対する研究開発投資の増加が、今後数年間のトゥレット症候群治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、ベンダー間の戦略的提携の増加と医療インフラへの支出の増加により、市場での需要が大幅に増加すると予想されます。

トゥレット症候群治療薬市場に関するレポートは、次の分野をカバーしています。

  • トゥレット症候群治療薬市場の規模
  • トゥレット症候群治療薬市場の予測
  • トゥレット症候群治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AstraZeneca Plc
    ➣ Bausch Health Companies Inc.
    ➣ Catalyst Pharmaceuticals Inc
    ➣ Eli Lilly and Co.
    ➣ Emalex Biosciences Inc.
    ➣ H Lundbeck AS
    ➣ Johnson and Johnson Services Inc.
    ➣ Medtronic Plc
    ➣ Neurocrine Biosciences Inc.
    ➣ 大塚ホールディングス(Otsuka Holdings Co. Ltd.)
    ➣ Paragon Biosciences LLC
    ➣ Questex LLC
    ➣ Reviva Pharmaceuticals Holdings Inc
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Tourettes Syndrome Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Antipsychotics - Market size and forecast 2023-2028
Chart on Antipsychotics - Market size and forecast 2023-2028 ($ million)
Data Table on Antipsychotics - Market size and forecast 2023-2028 ($ million)
Chart on Antipsychotics - Year-over-year growth 2023-2028 (%)
Data Table on Antipsychotics - Year-over-year growth 2023-2028 (%)
6.4 Non-antipsychotics - Market size and forecast 2023-2028
Chart on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
Data Table on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
Chart on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
Data Table on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.4 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
12.5 Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc - Overview
Catalyst Pharmaceuticals Inc - Product / Service
Catalyst Pharmaceuticals Inc - Key offerings
12.6 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.7 Emalex Biosciences Inc.
Emalex Biosciences Inc. - Overview
Emalex Biosciences Inc. - Product / Service
Emalex Biosciences Inc. - Key offerings
12.8 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product / Service
H Lundbeck AS - Key offerings
12.9 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.10 Medtronic Plc
Medtronic Plc - Overview
Medtronic Plc - Business segments
Medtronic Plc - Key news
Medtronic Plc - Key offerings
Medtronic Plc - Segment focus
12.11 Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc. - Overview
Neurocrine Biosciences Inc. - Product / Service
Neurocrine Biosciences Inc. - Key offerings
12.12 Otsuka Holdings Co. Ltd.
Otsuka Holdings Co. Ltd. - Overview
Otsuka Holdings Co. Ltd. - Business segments
Otsuka Holdings Co. Ltd. - Key news
Otsuka Holdings Co. Ltd. - Key offerings
Otsuka Holdings Co. Ltd. - Segment focus
12.13 Paragon Biosciences LLC
Paragon Biosciences LLC - Overview
Paragon Biosciences LLC - Product / Service
Paragon Biosciences LLC - Key offerings
12.14 Questex LLC
Questex LLC - Overview
Questex LLC - Product / Service
Questex LLC - Key offerings
12.15 Reviva Pharmaceuticals Holdings Inc
Reviva Pharmaceuticals Holdings Inc - Overview
Reviva Pharmaceuticals Holdings Inc - Product / Service
Reviva Pharmaceuticals Holdings Inc - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on Antipsychotics - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Antipsychotics - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Antipsychotics - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Antipsychotics - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Data Table on Market opportunity by Product ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Distribution Channel ($ million)
Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: AstraZeneca Plc - Overview
Exhibits110: AstraZeneca Plc - Product / Service
Exhibits111: AstraZeneca Plc - Key news
Exhibits112: AstraZeneca Plc - Key offerings
Exhibits113: Bausch Health Companies Inc. - Overview
Exhibits114: Bausch Health Companies Inc. - Business segments
Exhibits115: Bausch Health Companies Inc. - Key news
Exhibits116: Bausch Health Companies Inc. - Key offerings
Exhibits117: Bausch Health Companies Inc. - Segment focus
Exhibits118: Catalyst Pharmaceuticals Inc - Overview
Exhibits119: Catalyst Pharmaceuticals Inc - Product / Service
Exhibits120: Catalyst Pharmaceuticals Inc - Key offerings
Exhibits121: Eli Lilly and Co. - Overview
Exhibits122: Eli Lilly and Co. - Product / Service
Exhibits123: Eli Lilly and Co. - Key news
Exhibits124: Eli Lilly and Co. - Key offerings
Exhibits125: Emalex Biosciences Inc. - Overview
Exhibits126: Emalex Biosciences Inc. - Product / Service
Exhibits127: Emalex Biosciences Inc. - Key offerings
Exhibits128: H Lundbeck AS - Overview
Exhibits129: H Lundbeck AS - Product / Service
Exhibits130: H Lundbeck AS - Key offerings
Exhibits131: Johnson and Johnson Services Inc. - Overview
Exhibits132: Johnson and Johnson Services Inc. - Business segments
Exhibits133: Johnson and Johnson Services Inc. - Key news
Exhibits134: Johnson and Johnson Services Inc. - Key offerings
Exhibits135: Johnson and Johnson Services Inc. - Segment focus
Exhibits136: Medtronic Plc - Overview
Exhibits137: Medtronic Plc - Business segments
Exhibits138: Medtronic Plc - Key news
Exhibits139: Medtronic Plc - Key offerings
Exhibits140: Medtronic Plc - Segment focus
Exhibits141: Neurocrine Biosciences Inc. - Overview
Exhibits142: Neurocrine Biosciences Inc. - Product / Service
Exhibits143: Neurocrine Biosciences Inc. - Key offerings
Exhibits144: Otsuka Holdings Co. Ltd. - Overview
Exhibits145: Otsuka Holdings Co. Ltd. - Business segments
Exhibits146: Otsuka Holdings Co. Ltd. - Key news
Exhibits147: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits148: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits149: Paragon Biosciences LLC - Overview
Exhibits150: Paragon Biosciences LLC - Product / Service
Exhibits151: Paragon Biosciences LLC - Key offerings
Exhibits152: Questex LLC - Overview
Exhibits153: Questex LLC - Product / Service
Exhibits154: Questex LLC - Key offerings
Exhibits155: Reviva Pharmaceuticals Holdings Inc - Overview
Exhibits156: Reviva Pharmaceuticals Holdings Inc - Product / Service
Exhibits157: Reviva Pharmaceuticals Holdings Inc - Key offerings
Exhibits158: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits159: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits160: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits161: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits163: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits164: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits165: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits166: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Information sources
Exhibits172: Data validation
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Data synthesis
Exhibits175: 360 degree market analysis
Exhibits176: List of abbreviations

この商品のレポートナンバー

0000040423

TOP